Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Cancer and deep venous thrombosis: the purpose of the CATCH clinical trial].

Araújo A.

Acta Med Port. 2013 Mar-Apr;26(2):83-5. Epub 2013 May 31. Portuguese.

2.

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.

Meyer G, Marjanovic Z, Valcke J, Lorcerie B, Gruel Y, Solal-Celigny P, Le Maignan C, Extra JM, Cottu P, Farge D.

Arch Intern Med. 2002 Aug 12-26;162(15):1729-35.

PMID:
12153376
3.

CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients.

Lee AY, Bauersachs R, Janas MS, Jarner MF, Kamphuisen PW, Meyer G, Khorana AA; CATCH Investigators.

BMC Cancer. 2013 Jun 13;13:284. doi: 10.1186/1471-2407-13-284.

4.

Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.

Lee AY, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF, Khorana AA; CATCH Investigators.

JAMA. 2015 Aug 18;314(7):677-86. doi: 10.1001/jama.2015.9243.

PMID:
26284719
5.

Prophylaxis and treatment of venous thromboembolism in patients with cancer.

Ageno W, Squizzato A.

Intern Emerg Med. 2006;1(4):260-2. Review. No abstract available.

PMID:
17217144
6.

Thrombosis and cancer.

Kakkar AK.

Hematol J. 2004;5 Suppl 3:S20-3. Review.

PMID:
15190272
7.

Prophylaxis of catheter-related thrombosis in cancer patients.

Prandoni P.

Lancet. 2009 Feb 14;373(9663):523-4. doi: 10.1016/S0140-6736(09)60178-1. No abstract available.

PMID:
19217973
8.
9.

A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.

Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH.

J Bone Joint Surg Am. 2000 Jul;82-A(7):929-38.

PMID:
10901307
10.

Tinzaparin in the treatment of venous thromboembolism.

Pineo GF, Hull RD.

Expert Opin Pharmacother. 2003 Dec;4(12):2355-62.

PMID:
14640933
11.

Can we optimise treatment of thrombosis?

Levine MN.

Cancer Treat Rev. 2003 Jun;29 Suppl 2:19-22. Review.

PMID:
12887946
12.

[Heparin and cancer].

Lykke J.

Ugeskr Laeger. 2006 Dec 11;168(50):4397-401. Review. Danish.

PMID:
17217864
13.

Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?

Caine GJ, Lip GY.

Arch Intern Med. 2003 May 26;163(10):1243-4; author reply 1244. No abstract available.

PMID:
12767973
14.

[Controversies in oncology. Venous thromboembolism and cancer: what is done and what should be done. Milan, May 18, 2002].

[No authors listed]

Tumori. 2002 Jul-Aug;88(4):A8-17. Italian. No abstract available.

PMID:
12402833
15.

Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.

Lavau-Denes S, Lacroix P, Maubon A, Preux PM, Genet D, Vénat-Bouvet L, Labourey JL, Martin J, Slaouti P, Tubiana-Mathieu N.

Cancer Chemother Pharmacol. 2013 Jul;72(1):65-73. doi: 10.1007/s00280-013-2169-y. Epub 2013 May 1.

PMID:
23636449
16.

[Venous thromboembolism in oncologic patients: guidelines for prevention and therapy and areas of uncertainty].

Di Minno G, Tufano A.

Tumori. 2006 Nov-Dec;92(6):suppl 1-15. Review. Italian. No abstract available.

PMID:
17260505
17.

Community-based treatment of venous thromboembolism with a low-molecular-weight heparin and warfarin.

Hyers TM, Spyropoulos AC; INNOVATE Investigators.

J Thromb Thrombolysis. 2007 Dec;24(3):225-32. Epub 2007 Mar 3.

PMID:
17334932
18.

The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.

Cunningham RS.

Semin Oncol. 2006 Apr;33(2 Suppl 4):S17-25; quiz S41-2. Review.

PMID:
16638457
19.

Cancer and venous thromboembolism.

Prandoni P, Falanga A, Piccioli A.

Lancet Oncol. 2005 Jun;6(6):401-10. Review.

PMID:
15925818
20.

Selecting an anticoagulant for recurrent venous thromboembolism in cancer.

Goodin S.

Am J Health Syst Pharm. 2005 Nov 15;62(22 Suppl 5):S10-3.

PMID:
16286363

Supplemental Content

Support Center